One of the world pioneers in genome analysis, deCODE genetics Inc of Iceland, has filed for court-approved protection from its creditors under Chapter 11 of the US bankruptcy code. deCODE plans to sell its assets to a venture capital firm. ---Subscribe to MedNous to access this article--- Company News
